Wird geladen...
SUN-LB026 Do CFTR Modulators Treat Cystic Fibrosis-Related Diabetes?
Background: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are a recent advancement in the treatment of cystic fibrosis and were initially approved for their beneficial effect on lung function. There have also been few reports of their positive role in glycemic contro...
Gespeichert in:
| Veröffentlicht in: | J Endocr Soc |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Endocrine Society
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552780/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-LB026 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|